Skip to main content

Advertisement

SpringerLink
Log in

Central sympathoinhibitory effects of calcium channel blockers

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

It is generally assumed that the arterial vasodilation induced by inhibition of Ca2+ influx into vascular smooth muscle cells represents the main mechanism for the hypotensive effect of dihydropyridine calcium channel blockers. Increases in sympathetic tone have been related to activation of the arterial baroreflex by rapid lowering of blood pressure. This review highlights new findings in two areas. First, in animal studies, direct central administration of dihydropyridines such as nifedipine or amlodipine lowers sympathetic nerve activity and thereby blood pressure. Peripheral administration of nifedipine or amlodipine at low rates appears to result in gradual accumulation of drug in the central nervous system, and also causes lowering of sympathetic nerve activity and thereby lowering of blood pressure (rather than by arterial vasodilation). Second, in hypertensive humans treated with long-acting dihydropyridines and presumably little activation of the arterial baroreflex, some studies have demonstrated lowering of sympathetic activity (as assessed by plasma norepinephrine), but others reported increases (as assessed by plasma norepinephrine or microneurography). This sympathoexcitatory response may be due to activation of the reninangiotensin system, particularly at higher doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Julius S, Nesbitt S: Sympathetic nervous system as a coronary risk factor in hypertension. Cardiologia 1996, 41:309–317.

    PubMed  CAS  Google Scholar 

  2. Ruzicka M, Leenen FHH: Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium channel antagonists. In Hypertension: Pathophysiology, Diagnosis and Management, edn 2. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:2815–2825.

    Google Scholar 

  3. Leenen FHH: Dihydropyridine calcium antagonists and sympathetic activity: relevance to cardiovascular morbidity and mortality. In Calcium Antagonists in Clinical Medicine. Edited by Epstein M. Philadelphia: Hanley and Belfus, Inc.; 1998:527–552. This review provides an outline of the “classical” thinking regarding dihydropyridines and sympathetic activity, and the relevance of sympathetic hyperactivity for outcome.

    Google Scholar 

  4. Ishii K, Kano T, Kurobe Y, Ando J: Binding of [3H]nitrendipine to heart and brain memebranes from normotensive and spontaneously hypertensive rats. Eur J Pharmacol 1983, 88:277–278.

    Article  PubMed  CAS  Google Scholar 

  5. Akaike N, Kostyuk PG, Osipchuk YV: Dihydropyridinesensitive low-threshold calcium channels in isolated rat hypothalamic neurons. J Physiol 1989, 412:181–195.

    PubMed  CAS  Google Scholar 

  6. Igelmund P, Zhao YQ, Heinemann U: Effects of T-type, L-type, P-type, and Q-type calcium channel blockers on stimulusinduced pre- and post-synaptic calcium fluxes in rat hippocampal slices. Exp Brain Res 1996, 109:22–32.

    Article  PubMed  CAS  Google Scholar 

  7. Higuchi S, Takeshita A, Ito N, et al.: Arterial pressure and heart rate responses to calcium channel blockers administered in the brainstem in rats. Circ Res 1985, 57:244–251.

    PubMed  CAS  Google Scholar 

  8. Laurent S, Girerd X, Tsoukaris-Kupfer D, et al.: Opposite central cardiovascular effects of nifedipine and Bay K 8644 in anaesthetized rats. Hypertension 1987, 9:132–138.

    PubMed  CAS  Google Scholar 

  9. Huang BS, Leenen FHH: Sympathoinhibitory effects of central nifedipine in spontaneously hypertensive rats on high versus regular sodium intake. Hypertension 1999, 33:32–35. This paper provides the first direct evidence that central administration of a dihydropyridine can lower sympathetic nerve activity.

    PubMed  CAS  Google Scholar 

  10. Murzenok PP, Huang BS, Leenen FHH: Sympatho-inhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension 2000, 35:631–636. This study provides the first evidence that peripheral administration (intravenous infusion at low rates) of a dihydropyridine also can lower sympathetic nerve activity, and presumably therefore BP.

    PubMed  CAS  Google Scholar 

  11. Huang BS, Leenen FHH: Brain “ouabain” and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats. Hypertension 1996, 28:1005–1012.

    PubMed  CAS  Google Scholar 

  12. Galletti F, Rutledge A, Triggle DJ: Dietary sodium intake: influence on calcium channels and urinary calcium excretion in spontaneously hypertensive rats. Biochem Pharmacol 1991, 261:H1397-H1401.

    Google Scholar 

  13. Ooboshi H, Sadoshima S, Fujii K, et al.: Acute effects of antihypertensive agents on cerebral blood flow in hypertensive rats. Eur J Pharmacol 1990, 179:253–261.

    Article  PubMed  CAS  Google Scholar 

  14. Kleinbloesem CH, Van Brummelen P, Danhof M, et al.: Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther 1987, 41:26–30.

    Article  PubMed  CAS  Google Scholar 

  15. van Zwieten P: The pharmacological properties of lipophilic calcium channel antagonists. Blood Press 1998, 7(suppl 2):5–9.

    Google Scholar 

  16. Janicki PK, Siembab D, Paulo EA, Krzascik P: Single-dose kinetics of nifedipine in rat plasma and brain. Pharmacol 1988, 36:183–187.

    Article  CAS  Google Scholar 

  17. Larkin JG, Thompson GG, Scobie G, et al.: Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures. Epilepsia 1992, 33:760–769.

    Article  PubMed  CAS  Google Scholar 

  18. Uchida S, Tamada S, Nagai K, et al.: Brain pharmacokinetics and in vivo receptor bind of 1,4-dihydropyridine calcium channel antagonists. Life Sci 1997, 61:2083–2090.

    Article  PubMed  CAS  Google Scholar 

  19. Huang BS, Murzenok PP, Leenen FHH: Sympathoinhibitory and depressor responses to long-term infusion of nifedipine in spontaneously hypertensive rats on high-salt diet. J Cardiovasc Pharmacol 2000, 36:704–710.

    Article  PubMed  CAS  Google Scholar 

  20. Tsoporis J, Fields N, Leenen FHH: Contrasting effects of calcium antagonists vs. arterial vasodilators on cardiac anatomy and sympathetic activity in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991, 17(suppl 2):166–168.

    Google Scholar 

  21. Wyss JM, Yang R, Jin H, Oparil S: Hypothalamic microinjection of alpha2-adrenergic receptor agonists causes greater sympathoinhibition in spontaneously hypertensive rats on high NaCl diets. J Hypertens 1988, 6:805–813.

    Article  PubMed  CAS  Google Scholar 

  22. Calhoun DA, Zhu S: Pretreatment with enalaprilat blunts nicardipine-induced sympathetic activation in spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 1999, 17:507–512. This study provides the first clear evidence that dihydropyridine-induced sympathetic activation depends on the renin-angiotensin system.

    Article  PubMed  CAS  Google Scholar 

  23. Grassi G, Vailati S, Bertinieri G, et al.: Heart rate as marker of sympathetic activity. J Hypertens 1998, 16:1635–1639.

    Article  PubMed  CAS  Google Scholar 

  24. Grassi G, Esler M: How to assess sympathetic activity in humans. J Hypertens 1999, 17:719–734.

    Article  PubMed  CAS  Google Scholar 

  25. Murphy MB, Scriven AJ, Brown MJ, et al.: The effects of nifedipine and hydralazine induced hypotension on sympathetic activity. Eur J Clin Pharmacol 1982, 23:479–482.

    Article  PubMed  CAS  Google Scholar 

  26. Leenen FHH, Burns RJ, Myers MG, Frankel D: Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy. Cardiovasc Drug Ther 1990, 4:499–504.

    Article  CAS  Google Scholar 

  27. Sasaguri M, Matsumoto N, Noda K, et al.: Amlodipine lowers blood pressure without increasing sympathetic activity or activating renin-angiotensin system in patients with essential hypertension. Eur J Clin Pharmacol 1997, 53:197–201.

    Article  PubMed  CAS  Google Scholar 

  28. Hamada T, Watanabe M, Kaneda T, et al.: Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J Hypertens 1998, 16:111–118.

    Article  PubMed  CAS  Google Scholar 

  29. Leenen FHH, Fourney A: Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass. Am J Cardiol 1996, 78:203–207.

    Article  PubMed  CAS  Google Scholar 

  30. Argenziano L, Izzo R, Iovino G, et al.: Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients. Blood Press 1998, 7(suppl 1):9–14.

    Article  Google Scholar 

  31. de Champlain J, Karas M, Nguyen P, et al.: Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998, 16:1357–1369.

    Article  Google Scholar 

  32. Dodt C, Struck J, Muck D, et al.: Different effects of valsartan and amlodipine on muscle sympathetic activity in hypertensive subjects [abstract]. J Hypertension 2000, 18(suppl 4):S29.

    Google Scholar 

  33. Lichtenberg G, Blankestijn PJ, Oey L, et al.: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999, 340:1321–1328. This study clearly demonstrates that treatment with the long-acting dihydropyridine, amlodipine, at the higher dose of 10 mg/d effectively lowers BP. However, it is associated with activation of the renin-angiotensin system and a significant increase in muscle sympathetic nerve activity.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hypertension Unit, University of Ottawa Heart Institute, 40 Ruskin Street, K1Y 4W7, Ottawa, Ontario, Canada

    Frans H. H. Leenen MD, PhD, FRCPC, Marcel Ruzicka MD, PhD & Bing S. Huang MD, PhD

Authors
  1. Frans H. H. Leenen MD, PhD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcel Ruzicka MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bing S. Huang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leenen, F.H.H., Ruzicka, M. & Huang, B.S. Central sympathoinhibitory effects of calcium channel blockers. Current Science Inc 3, 314–321 (2001). https://doi.org/10.1007/s11906-001-0094-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-001-0094-7

Keywords

Search

Navigation